Defence Therapeutics Inc. (CSE:DTC)
Canada
· Delayed Price · Currency is CAD 0.520
-0.030 (-5.45%)
Apr 28, 2026, 3:59 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 39.31 million as of April 28, 2026. Its market cap has decreased by -31.60% in one year.
Market Cap
39.31M
Enterprise Value
39.85M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 39.31M, a decrease of -55.88%. That is a compound annual growth rate of -15.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 39.31M | -4.84% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedMira | 42.10M |
| BriaCell Therapeutics | 38.43M |
| Telescope Innovations | 37.98M |
| Lobe Sciences | 36.93M |
| Microbix Biosystems | 33.82M |
| Devonian Health Group | 33.09M |
| Medicenna Therapeutics | 54.22M |
| NurExone Biologic | 54.31M |